-
Share
26,843 Posts.
1309
18/12/20
11:45
Share
DVL
(from the thread)
Growth at +33% CAGR last three years is pretty good.
Revenue this year should be +$2.5m based on existing accounts.
BUT it's the horizon 2 customers that will drive price momentum.
$12m market cap compared to peers just doesn't stack up.
Should see this move towards 8c very soon.
The Medtronic trial is a MASSIVE achievement - they provide access to 1,000's of clinics globally.
The market will catch on, accumulate at these prices.
-
